#CareTalk March 2019: Gottlieb ’ s out. What ’ s next for FDA?
The latest edition of #CareTalk is out. CareCentrix CEO, John Driscoll and I explore the departure of FDA Director Scott Gottlieb and other pressing topics.
Here’s what we covered:
(0:28) Scott Gottlieb is out at FDA. Are you sad to see him go?
(2:00) Home health spending is projected to grow faster than any other category of healthcare over the coming years. Is that good or bad?
(4:00) Insulin prices are spiking and both Democrats and Republicans are up in arms. What’s happening?
(5:53) Lyft is talking about the social determinants of health. What?!
(8:47) What do you think about FDA approving ketamine nasal spray as a treatment for depression?
(9:10) What did we learn about healthcare from Michael Cohen’s Congressional testimony?
(9:33) Medicare has a new app. Have you tried it?
(9:59) Did you hear about the $48,500 bill for a cat bite?
Subscribe to the #CareTalk Podcast
iTunes: https://apple.co/2DIDTcr
Google Play: https://bit.ly/2RobqMB
Source: Health Business Blog - Category: Health Management Authors: dewe67 Tags: Blogs Podcast Policy and politics carecentrix FDA home care insulin Lyft Source Type: blogs
More News: Blogging | Depression | Health Management | Insulin | Learning | Medicare | Podcasts | Politics | Universities & Medical Training